Centogene Gross Profit 2019-2023 | CNTG
Centogene gross profit from 2019 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Centogene Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2022 | $21 |
| 2021 | $33 |
| 2020 | $48 |
| 2019 | $26 |
| 2018 | $24 |
| Centogene Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2023-06-30 | |
| 2022-06-30 | $5 |
| 2022-03-31 | $4 |
| 2021-12-31 | $14 |
| 2021-09-30 | $-6 |
| 2021-06-30 | $10 |
| 2021-03-31 | $16 |
| 2020-12-31 | $27 |
| 2020-09-30 | $12 |
| 2020-06-30 | $3 |
| 2020-03-31 | $6 |
| 2019-09-30 | $6 |
| 2019-06-30 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.050B |
| Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
| Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
| Axonics (AXNX) | United States | $3.432B | 0.00 |
| 10x Genomics (TXG) | United States | $3.275B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.196B | 0.00 |
| Azenta (AZTA) | United States | $2.979B | 242.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
| Enovis (ENOV) | United States | $2.812B | 20.84 |
| Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.224B | 98.63 |
| Schrodinger (SDGR) | United States | $1.712B | 0.00 |
| Omnicell (OMCL) | United States | $1.384B | 47.83 |
| Phreesia (PHR) | United States | $1.259B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
| Standard BioTools (LAB) | United States | $0.728B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
| Pulmonx (LUNG) | United States | $0.378B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| Outset Medical (OM) | United States | $0.162B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
| TruBridge (TBRG) | United States | $0.125B | 5.33 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
| 111 (YI) | China | $0.096B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.046B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |